EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Targeting angiotensinogen for the upstream prevention of hypertension and cardiovascular disease

Anthony J. Viera, Neha J. Pagidipati

American Journal of Preventive Cardiology · 2026-10 · 102560

DOI: 10.1016/j.ajpc.2026.102560 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Preventive Cardiology, 2026-10. Verfasst von Anthony J. Viera und 1 weiteren Autor:innen. Die Arbeit nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Uncontrolled hypertension remains the single greatest contributor to cardiovascular disease morbidity and mortality worldwide. Even modest elevations, so-called “high-normal” BP levels, confer significant risk over the course of a lifetime. However, the current treatment paradigm remains rooted in a threshold-based strategy in which treatment is only initiated after BP exceeds predefined cut-points, leaving many who might benefit over the long term untreated. Shifting the paradigm towards earlier treatment and prevention of overt hypertension would require a target that is upstream, durable, and demonstrably safe for long-term use in lower-risk populations. In this review, we examine the concept that targeting angiotensinogen, the most upstream precursor in the renin–angiotensin–aldosterone system (RAAS), could contribute to an earlier, trajectory-focused strategy for preventing hypertension and cardiovascular disease. We review the rationale for targeting angiotensinogen, summarize the evidence for current agents in development, and propose a research agenda to determine whether this approach can safely delay or prevent incident hypertension in selected at-risk populations.

Zitieren

APA

Viera, A. J., & Pagidipati, N. J. (2026). Targeting angiotensinogen for the upstream prevention of hypertension and cardiovascular disease. American Journal of Preventive Cardiology, 102560. https://doi.org/10.1016/j.ajpc.2026.102560

Vancouver

Viera AJ, Pagidipati NJ. Targeting angiotensinogen for the upstream prevention of hypertension and cardiovascular disease. American Journal of Preventive Cardiology. 2026:102560. doi:10.1016/j.ajpc.2026.102560

BibTeX
@article{Viera2026,
  author = {Viera, Anthony J. and Pagidipati, Neha J.},
  title = {Targeting angiotensinogen for the upstream prevention of hypertension and cardiovascular disease},
  journal = {American Journal of Preventive Cardiology},
  year = {2026},
  pages = {102560},
  doi = {10.1016/j.ajpc.2026.102560}
}
Kostenlos starten →